6-Gingerol, a
natural product of ginger, has been known to possess anti-tumorigenic and pro-apoptotic activities. However, the mechanisms by which it prevents
cancer are not well understood in human
colorectal cancer.
Cyclin D1 is a proto-oncogene that is overexpressed in many
cancers and plays a role in cell proliferation through activation by
beta-catenin signaling. Nonsteroidal anti-inflammatory
drug (
NSAID)-activated gene-1 (NAG-1) is a
cytokine associated with pro-apoptotic and anti-tumorigenic properties. In the present study, we examined whether
6-gingerol influences
cyclin D1 and NAG-1 expression and determined the mechanisms by which
6-gingerol affects the growth of human
colorectal cancer cells in vitro.
6-Gingerol treatment suppressed cell proliferation and induced apoptosis and G(1) cell cycle arrest. Subsequently,
6-gingerol suppressed
cyclin D1 expression and induced NAG-1 expression.
Cyclin D1 suppression was related to inhibition of
beta-catenin translocation and
cyclin D1 proteolysis. Furthermore, experiments using inhibitors and
siRNA transfection confirm the involvement of the PKCepsilon and
glycogen synthase kinase (GSK)-3beta pathways in 6-gingerol-induced NAG-1 expression. The results suggest that
6-gingerol stimulates apoptosis through upregulation of NAG-1 and G(1) cell cycle arrest through downregulation of
cyclin D1. Multiple mechanisms appear to be involved in
6-gingerol action, including protein degradation as well as
beta-catenin, PKCepsilon, and
GSK-3beta pathways.